Horse Therapy for Children, Adolescents and Young Adults in Remission From Medulloblastoma

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

15 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-03

Study Completion Date

2026-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

On average, each year in the former region, 60 new patients under the age of 18 are treated for a brain tumor, with an active post-treatment follow-up file of 350 patients. Because of the significant sequelae induced by the disease or the treatments, these patients will very often require rehabilitative care.

The interest of involving the horse in the population of patients cured of a medulloblastoma but with important physical and psychological after-effects is to be able to combine a therapy using animal mediation (equitherapy) and a rehabilitation therapy based on the three-dimensional movement of the horse (hippotherapy).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

MEDIR Medulloblastome

NCT01197924

Child Cancer Brain

UNKNOWN

Social Participation After Childhood Craniopharyngioma

NCT03139526

Children With a Craniopharyngioma

COMPLETED

Components of Social Functioning in Survivors of Pediatric Brain Tumors

NCT03361033

Brain Tumor, Pediatric Medulloblastoma, Pediatric

COMPLETED

Proton Beam Radiation Therapy in Treating Young Patients Who Have Undergone Biopsy or Surgery for Medulloblastoma or Pineoblastoma

NCT00105560

Brain and Central Nervous System Tumors Long-term Effects Secondary to Cancer Therapy in Children

COMPLETED NA

Follow-up Survey of Patients Who Were Treated for Medulloblastoma or Primitive Neuroectodermal Tumors of the Central Nervous in Norway

NCT02851355

Brain Tumor

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neuroblastoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

horse therapy

Group Type EXPERIMENTAL

horse therapy

Intervention Type OTHER

equitherapy and hippotherapy once a week during 16 weeks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

horse therapy

equitherapy and hippotherapy once a week during 16 weeks

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* complete remission of medulloblastoma and after 5 years of the end of treatment
* living within 30 km away the riding center and/or less than 1 hour of transport
* informed consent